Share on LinkedInShare on LinkedIn

ARTICLE · 15 JANUARY 2018

Business Before The Budget

There is a spectre haunting the tax-advantaged market: the Patient Capital Review. The thinking of the Treasury is much remarked upon, but little known, with mentions like that of the Chancellor's...

United KingdomStrategy

Simon Radford looks at the challenges to capacity, and the constraints inherent in the tax-advantaged sector, in light of the Patient Capital Review and other trends in the sector.

There is a spectre haunting the tax-advantaged market: the Patient Capital Review. The thinking of the Treasury is much remarked upon, but little known, with mentions like that of the Chancellor's in his party conference speech mined for potential hints. While many of us have had conversations with policymakers in terms of the consultation, launched a couple of months ago, speculation has varied as to their true intentions: some managers raise the possibility of a National Investment Bank for early-stage investments, much like those funds deployed by managers as part of the British Business Bank's "Northern Powerhouse Investment Funds". Others reassure the sector that changes will be incremental more than radical, while lobby groups representing both EIS and VCT managers seem ready to

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from